as attached
Awaiting price reaction for this filing.
Kashyap Tele-Medicines Limited reported its Q1 FY26 results on August 14, 2025. Revenue from operations fell sharply to ₹3.90 lakhs, down from ₹19.20 lakhs in the same quarter last year — an approximate 80% year-on-year decline. Total expenses stood at ₹2.98 lakhs versus ₹5.56 lakhs a year ago. The company swung from a small profit of ₹0.34 lakhs in Q1 FY25 to a loss of ₹2.98 lakhs before tax and PAT in Q1 FY26. EPS turned negative at ₹(0.006). The auditor (Ravi Karia & Associates) issued an unqualified limited review report with no qualifications or emphasis-of-matter paragraphs.
Negative for shareholders — steep revenue contraction and a return to losses signal weak business momentum. Notably, the company's other equity stands at a deeply negative ₹(413.27) lakhs against share capital of ₹477.22 lakhs, indicating accumulated losses and raising questions about long-term financial sustainability.